Nahar Capital & Financial Services Ltd. has fulfilled its regulatory obligations by submitting the mandatory DEMAT certificate for the quarter ended March 2026 to stock exchanges. The non-banking financial company completed this submission in accordance with SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Submission

Company Secretary Anjali Modgil submitted the DEMAT certificate to both the National Stock Exchange of India Limited and BSE Limited on April 6, 2026. The submission was made pursuant to Regulation 74(5) of the SEBI Depositories Regulations, which mandates quarterly reporting of dematerialization activities.

Registrar Certification

Alankit Assignments Ltd., serving as the Registrar and Transfer Agent, issued the certificate on April 4, 2026. General Manager Kamal Garg digitally signed the certification document, confirming compliance with regulatory requirements for the quarter ended March 31, 2026.

The certificate confirms two critical compliance aspects:

• Securities comprised in the certificates have been listed on stock exchanges
• Physical certificates have been properly verified, mutilated, cancelled, and depository names substituted in company records as registered owners

Company Information

Nahar Capital and Financial Services Ltd. operates as a non-banking financial company with its registered and corporate office located at Nahar Tower, 375 Industrial Area-A, Ludhiana. The company is incorporated under CIN L45202PB2006PLC029968 and maintains its digital presence through www.ownnahar.com .

Administrative Details

Alankit Assignments Ltd. holds multiple SEBI registrations and operates from its registered office at Anarkali Complex, Jhandewalan Extension, New Delhi. The registrar maintains both Delhi and Mumbai offices to serve its client base across major financial centers.

This quarterly submission represents standard regulatory compliance for listed companies, ensuring transparency in share dematerialization processes and maintaining accurate depository records for investor protection.

Vivo Bio Tech Limited has issued a comprehensive newspaper notice to inform shareholders about a special window for physical share transfer and dematerialisation. The biotechnology company, headquartered in Hyderabad, has announced this initiative to assist shareholders in meeting regulatory requirements pursuant to SEBI guidelines.

Special Window for Physical Share Transfer

Pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, the company has opened a special window for shareholders to facilitate transfer and dematerialisation requests for physical securities. This initiative addresses specific regulatory requirements for legacy shareholdings.

The special window accommodates two categories of investors: those who had not lodged transfer of shares, and those who had lodged shares for transfer but were rejected, returned, or not attended to due to deficiencies in documentation.

Eligibility Matrix for Shareholders

The company has provided a clear eligibility matrix to help shareholders understand their qualification for the special window:

Registrar and Transfer Agent Information

Shareholders are directed to contact the company's appointed Registrar and Share Transfer Agent for all transfer-related activities:

Aarthi Consultants Private Limited

• Unit: Vivo Bio Tech Limited
• Address: 1-2-285, Domalguda, Hyderabad - 500029, Telangana, India
• Phone: 040-27638111
• Email: info@aarthiconsultants.com

Documentation Requirements

The company has specified that only requests accompanied by original share certificates along with transfer deeds and other supporting documents will be considered under the special window. Shareholders must submit their applications within the stipulated period to avail of this facility.

For further details, investors may refer to the SEBI circular available on the regulator's official website. The notice was signed by A V Kiran, Company Secretary, and published on April 06, 2026. This initiative demonstrates the company's commitment to regulatory compliance and shareholder service enhancement.